January 25, 2012 — The US Food and Drug Administration (FDA) has given the go-ahead for the use of levetiracetam (Keppra, UCB Pharmaceuticals) as adjunctive treatment for partial-onset seizures in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback